
MBBS
takhzyro (lanadelumab-flyo injection)
- Generic Name: lanadelumab-flyo
- Manufactured by : shire
- Drug Strength : 300mg
How It Works
Takhzyro (lanadelumab-flyo) is a monoclonal antibody that works by inhibiting plasma kallikrein, an enzyme that plays a crucial role in the pathway that leads to the production of bradykinin. Bradykinin is a peptide that causes blood vessels to dilate and become leaky, leading to the symptoms of hereditary angioedema (HAE). By blocking plasma kallikrein, Takhzyro reduces the frequency and severity of HAE attacks.
List of Side Effects
- Injection site reactions
- Upper respiratory infections
- Headache
- Dizziness
- Rash
- Muscle pain
- Diarrhea
- Fever
- Abdominal pain
- Nausea
List of Indications
- Prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients 12 years and older
List of Contraindications
- Severe hypersensitivity to lanadelumab-flyo or any of the excipients in Takhzyro
Price in Different Countries
Country | Price (USD) | Reference Website |
---|---|---|
United States | $24,000 | GoodRx |
United Kingdom | £18,000 | NICE BNF |
Canada | $30,000 CAD | CanadaDrugs.com |
Australia | $35,000 AUD | PBS Australia |
India | ₹1,800,000 INR | 1mg |
Pakistan | ₨ 3,800,000 PKR | Dawaai.pk |
Top 5 Global Brands
- Takhzyro (Lanadelumab-flyo) – Takeda
- Haegarda (C1 Esterase Inhibitor Subcutaneous [Human]) – CSL Behring
- Firazyr (Icatibant) – Shire (part of Takeda)
- Berinert (C1 Esterase Inhibitor [Human]) – CSL Behring
- Ruconest (Recombinant C1 Inhibitor) – Pharming Group
One of the following licensed pharmacy from the nearest location will deliver takhzyro (lanadelumab-flyo injection). The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.
Questions and Answers
There are no questions yet. Be the first to ask a question about this product.
Reviews
There are no reviews yet.